🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Exact Sciences Corporation

Exact Sciences Corporation logo
Market Cap: Highest
Employees: High

Cologuard

Exact Sciences Corporation provides cancer screening and diagnostic test products, including the non-invasive Cologuard test for colorectal cancer, Oncotype DX gene expression tests, and other specialized cancer diagnostics.

Tags: Cologuard, Oncotype DX, biomarkers, cancer screening, diagnostic tests, gene expression, medical diagnostics

Symbol: EXAS

Recent Price: $56.20

Industry: Medical - Diagnostics & Research

CEO: Mr. Kevin T. Conroy

Sector: Healthcare

Employees: 6500

Address: 5505 Endeavor Lane, Madison, WI 53719

Phone: 608 284 5700

Leadership

  • Kevin Conroy, Chairman and CEO
  • Aaron Bloomer, Executive Vice President, Finance
  • Sarah Condella, Executive Vice President, Human Resources
  • Brian Baranick, Executive Vice President, General Manager, Precision Oncology
  • Jake Orville, Executive Vice President, General Manager, Screening
  • Dirk Zimmermann, General Manager, International
  • Ana Hooker, Chief Laboratory Officer
  • Veronica Descotte, Senior Vice President, Chief Strategy Officer
  • Nassar Nizami, Chief Information Officer
  • James Herriott, Senior Vice President, General Counsel and Secretary
  • Jorge Garces, Chief Science Officer
  • Morry Smulevitz, Senior Vice President, Corporate Affairs
  • Graham Lidgard, Chief Science Officer, Emeritus
  • Rick Baehner, Chief Medical Officer, Precision Oncology
  • Tomasz Beer, Chief Medical Officer, Multi-Cancer Early Detection
  • Steven Bellamy, Chief Medical Officer, International
  • Paul Limburg, Chief Medical Officer, Screening
  • Daniel Levangie, Governor
  • James E. Doyle, Director
  • Katherine S. Zanotti, Secretary
  • Kathleen Sebelius, Director
  • Mike Barber, Director
  • Paul Clancy, Director
  • Scott Coward, Director
  • Shacey Petrovic, Director

Last updated: 2024-12-31